Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
It must be administered in a clinic under medical supervision
3,4 The decision was based on results from the landmark LEADER trial demonstrating that liraglutides significant reduction in the risk of a three-component endpoint consisting of cardiovascular death, non-fatal heart attack, or non-fatal stroke by 13% versus placebo (P = .01) with an absolute risk reduction (ARR) of 1.9%
Putting a complex medication into a patch isn't as easy as it sounds
MHRA Guidance on Obtaining and Using Unlicensed Medicines Supplying or obtaining retatrutide outside an authorised clinical trial is illegal under UK law
US$ 20.80
US$ 24.10
US$ 26.42
